UNIVEC Selected by Johns Hopkins

Univec, Inc. (OTCBB: UNVC) a specialty pharmaceutical,
auto-disabled and safety syringe healthcare organization announced
that it completed an agreement with Johns Hopkins Hospital to provide
a specialty pharmaceutical for its medical facilities. 
   Raphael Langford, Executive Vice President and COO of Univec
stated. "This is a time of excitement for the company to be selected
by Johns Hopkins. We look forward to building on this relationship."

   About Univec

   Founded in 1992, Univec is a specialty pharmaceutical,
auto-disable safety syringes healthcare organization. The Company
license, manufactures, distributes and markets specialty
pharmaceuticals and healthcare products.

   PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a division of
Univec assists pharmaceutical companies in the promotion and payment
of prescription drugs though its network of pharmacies. PPSI
eliminates the need for the pharmaceutical companies to distribute
actual drug samples directly to physicians reducing potential
liability and including the pharmacist in the clinical oversight and
drug interaction checks for the patient.

   Forward Looking Statements

   This document contains forward-looking statements based on current
expectations that could be affected by the risks and uncertainties
involved in Univec's business. These risks and uncertainties include,
but are not limited to, the risks described from time to time in
Univec's reports to the Securities and Exchange Commission, which
include Univec's Annual Report on Form 10-K. Subsequent written or
oral statements attributable to Univec or persons acting on its behalf
are expressly qualified in their entirety by the cautionary statements
in this document and those in Univec's reports filed with the
Securities and Exchange Commission.